Glioma
Research News and Information

Saturday, November 21, 2009

Alexander disease: An important mimicker of focal brainstem glioma.

13 Dec 2009 We report the case of a 6-year-old male who was referred to a tertiary oncology center with a focal brainstem lesion which was presumed to be neoplastic. Due to the symmetric nature of the lesion on magnetic resonance imaging, the evaluation was ... Read more...

PARP1 expression in pediatric central nervous system tumors.

13 Dec 2009 BACKGROUND: Despite advances in therapy, outcome in many high-grade pediatric central nervous system (CNS) tumors remains poor. The focus of neuro-oncology research has thus turned towards identifying novel therapeutic targets. Poly(ADP-ribose) ... Read more...

Ceramide metabolism determines glioma cell resistance to chemotherapy.

29 Nov 2009 Tumor cell resistance to chemotherapy constitutes a major problem in the treatment of malignant tumors. We here investigated the role of ceramide metabolism for the resistance of glioma cells to treatment with the chemotherapeutic drug, gemcitabine. ... Read more...

Latest indexed articles for 'Glioma'

These are the very latest articles for this heading:

• Alexander disease: An important mimicker of focal brainstem glioma. 13 Dec 2009
• PARP1 expression in pediatric central nervous system tumors. 13 Dec 2009
• Ceramide metabolism determines glioma cell resistance to chemotherapy. 29 Nov 2009
• Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin. 29 Nov 2009
• Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. 13 Nov 2009
• Radiopathological characteristics of cerebellar malignant glioma in adults. 25 Oct 2009
• Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19. 29 Sep 2009
• Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells. 29 Sep 2009
• 6-year-old girl with hydrocephalus. 29 Sep 2009
• Dendritic cell therapy of high-grade gliomas. 29 Sep 2009
• Immunotherapy of diffuse gliomas: biological background, current status and future developments. 29 Sep 2009
• Immunotherapy of diffuse gliomas: helping the brain fight back! 29 Sep 2009
• Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics. 29 Sep 2009
• Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice. 29 Sep 2009
• Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis. 29 Sep 2009
• Comment on "Hypericin uptake: a prognostic marker for survival in high-grade glioma". 29 Sep 2009
• Evidence of a large-scale network underlying language switching: a brain stimulation study. 29 Sep 2009
• Intraoperative mapping and monitoring of brain functions for the resection of low-grade gliomas: technical considerations. 29 Sep 2009
• Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas. 29 Sep 2009
• Analysis of IDH1 and IDH2 mutations in Japanese glioma patients. 29 Sep 2009

See a longer list of these articles.

Technical information about 'Glioma'

Definition: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Descriptor UI: D005910

Alternative terms: Glioma; Gliomas; Glial Cell Tumors; Glial Cell Tumor; Tumor, Glial Cell; Tumors, Glial Cell; Mixed Glioma; Glioma, Mixed; Gliomas, Mixed; Mixed Gliomas; Malignant Glioma; Glioma, Malignant; Gliomas, Malignant; Malignant Gliomas;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.557.465.625.600.380; C04.557.470.670.380; C04.557.580.625.600.380;

Technical Notes: coord IM with precoord CNS/neopl term + site (IM); GLIOMA, SUBEPENDYMAL is available; for sarcomatous GLIOMA use GLIOSARCOMA; for GLIOMA, RETINAL see RETINOBLASTOMA